Article Information
History
- December 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sophie Samuel, PharmD, MS, BCCCP1,*,
- Kyndol Craver, PharmD1,
- Charles Miller, PhD2,
- Brittany Pelsue, PharmD, BCPS, BCCCP1,
- Catherine Gonzalez, BCS3,
- Teresa A Allison, PharmD, BCPS, BCCCP, FCCM1,
- Brian Gulbis, PharmD1,
- H Alex Choi, MD, MS4 and
- Seokhun Kim, PhD2
- 1Department of Pharmacy, Memorial Hermann Hospital, Houston, Texas, USA
- 2Institute for Clinical Research and Learning Health Care, UT Health Houston, Houston, Texas, USA
- 3Department of Neurology, UT Health Houston, Houston, Texas, USA
- 4Department of Neurosurgery, UT Health Houston, Houston, Texas, USA
- ↵*Corresponding author:
Sophie Samuel, PharmD, MS, 6411 Fannin Street, Houston, Texas 77030, Sophie.Samuel{at}memorialhermann.org
Kyndol.craver{at}osumc.edu, Charles.C.Miller{at}uth.tmc.edu, Brittany.Pelsue{at}memorialhermann.org, Catherine.Gonzalez{at}uth.tmc.edu, Teresa.Allison{at}memorialhermann.org, Brain.Gulbis{at}memorialhermann.org, Huimahn.A.Choi{at}uth.tmc.edu, Seokhun.kim{at}uth.tmc.edu
Posted December 07, 2023.
Effect of Renin-Angiotensin System (RAS) Inhibitors in Acute Ischemic Stroke to Improve Outcomes in In-Patient Settings: A Cross Sectional and Longitudinal Analysis
